-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on Sionna Therapeutics, Raises Price Target to $55

Benzinga·05/18/2026 16:56:21
Listen to the news
Stifel analyst Paul Matteis maintains Sionna Therapeutics (NASDAQ:SION) with a Buy and raises the price target from $44 to $55.